Doctolib: Europe’s Largest Health Appointment Platform
Doctolib is France’s most valuable healthtech company at €6.4 billion valuation, serving 80+ million patients across France, Germany, and Italy. Founded in 2013 by Stanislas Niox-Chateau, it has become essential infrastructure for European healthcare access.
Key Metrics
| Metric | Value |
|---|---|
| Valuation | €6.4 billion |
| Patients | 80+ million |
| Healthcare Professionals | 380,000+ |
| Monthly Appointments | 80+ million |
| Countries | France, Germany, Italy |
| Employees | 3,000+ |
| Revenue (est. 2024) | €500M+ ARR |
Product Suite
Appointment Booking: Patients book GP, specialist, and dentist appointments online in real-time. Teleconsultation: Launched during COVID, now handles millions of video consultations annually. Practice Management: Full EHR/EMR, billing, and patient communication tools for practitioners. Doctolib Hospital: Enterprise solution for hospital systems managing outpatient scheduling at scale.
Strategic Positioning
Doctolib operates in a winner-takes-most market. In France, 50%+ of the population uses the platform. Network effects are powerful: more doctors attract more patients, which attracts more doctors. The expansion to Germany (Europe’s largest healthcare market) and Italy positions Doctolib as a pan-European healthcare infrastructure company comparable to what Veeva Systems is to pharma CRM.
Investor Thesis
Doctolib’s path to IPO is widely anticipated as one of the next major European tech listings. Revenue growth exceeds 40% annually. The platform’s data assets (anonymized healthcare utilization data) represent significant secondary value for population health analytics and France 2030 health initiatives.